New Study Reveals Midlife Menopause as Critical Period for Alzheimer's Risk in Women
Loading more articles...
Mid-Life Menopause: Key Window for Women's Alzheimer's Risk, New Study Reveals
N
News18•18-03-2026, 09:28
Mid-Life Menopause: Key Window for Women's Alzheimer's Risk, New Study Reveals
•A new review challenges the assumption that women's higher Alzheimer's risk is solely due to longer lifespans, linking it to menopausal hormonal changes.
•The study, led by Dr. Lisa Mosconi, suggests the sharp drop in estrogen during menopause may directly trigger early Alzheimer's-related brain changes.
•Women's lifetime risk of Alzheimer's at age 45 is 1 in 5, double that of men, with estrogen's protective role highlighted as central.
•Brain scans show increased Alzheimer's biomarkers in postmenopausal women, and later menopause (after 55) is linked to a reduced risk.
•The review calls for a paradigm shift, viewing midlife neuroendocrine aging as a critical window for prevention and intervention, including careful consideration of hormone therapy.
